We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Malfunctioning microRNAs Linked to Development of Lupus in Mouse Models

By LabMedica International staff writers
Posted on 16 Feb 2011
Another important regulatory role has been identified for microRNA, this time in activating molecular pathways leading to development of the severe autoimmune disorder lupus.

Lupus, which affects more than five million people worldwide, is a chronic autoimmune disease of connective tissue that causes the body's immune system to become hyperactive and attack normal, healthy tissue. More...
The processes leading to development of lupus have so far not been identified.

In an effort to rectify the situation, investigators at Virginia Polytechnic Institute and State University (Blacksburg, USA) used miRNA microarray assays and RT- (real-time)-PCR to measure miRNA expressions in splenic lymphocytes from three mouse lupus models (MRL-lpr, B6-lpr, and NZB/WF1) with different genetic backgrounds. The different models were distinguished by the age at which the animals began to develop lupus (as early as three months or as late as nine months, depending on the strain).

Results published in the December 10, 2010, online edition of the journal PLoS One revealed that despite the genetic differences among the three lupus stains, a common set of dysregulated miRNAs (miR-182-96-183 cluster, miR-31, and miR-155) was present in splenocytes that differed from the miRNAs found in age-matched control mice. The association of these miRNAs with the disease was highlighted by the observation that this miRNA expression pattern became evident in NZB/WF1 mice only at the age when lupus disease was manifested.

Given that miRNAs are conserved, with regard to both evolution and function, the observation of a common lupus disease-associated miRNA expression pattern in mouse lupus models is likely to have significant pathogenic, diagnostic, and/or therapeutic implications for human lupus.

"In the short term, we want to use our better understanding of the disease to develop a tool in the form of molecular markers for early, reliable diagnosis,” said senior author Dr. S. Ansar Ahmed, professor of immunology at Virginia Polytechnic Institute and State University. "The long-term goal is to offer entirely new therapeutic approaches, such as manipulation of lupus-related miRNA, to correct pathological conditions.”

"If we can do this in a mouse model and then to cure other animals, hopefully it can one day be done in humans,” said Dr. Ahmed. "This is long-range research but modern technology is narrowing the time it takes from mouse to human — speeding translation.”

Related Links:
Virginia Polytechnic Institute and State University



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Automatic CLIA Analyzer
Shine i6000
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.